Screening of jaundiced neonates for glucose-6-phosphate dehydrogenase deficiency

Southern Medical Journal
|February 1, 1987
PubMed

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, typically X-linked, was unexpectedly common in female infants. Researchers recommend G6PD screening for all jaundiced newborns, regardless of sex, due to high prevalence in girls.

Area of Science:

  • Medical Genetics
  • Neonatal Medicine
  • Pediatric Hematology

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder.
  • This inheritance pattern suggests female infants are rarely affected.
  • Jaundice is a common symptom in newborns with G6PD deficiency.

Purpose of the Study:

  • To investigate the frequency of G6PD deficiency in jaundiced newborn infants.
  • To determine if the prevalence of G6PD deficiency in female infants is higher than expected.
  • To inform recommendations for G6PD screening in newborns.

Main Methods:

  • Retrospective review of medical records.
  • Screening of 1,478 jaundiced newborn infants (728 boys, 750 girls) for G6PD deficiency.
  • Analysis of G6PD deficiency prevalence by sex.

Main Results:

  • G6PD deficiency was identified in 5.6% of boys and 2.2% of girls.
  • The observed frequency in female infants was higher than anticipated.
  • A significant number of female infants presented with G6PD deficiency.

Conclusions:

  • The high frequency of G6PD deficiency in female infants is unexplained.
  • Screening for G6PD deficiency should be considered in selected jaundiced infants.
  • Screening recommendations should include infants of both sexes, irrespective of gender.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...